The Cardiac Marker Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global Cardiac Marker market has experienced significant growth recently. The market was worth $11.26 billion in 2024 and is expected to increase to $12.47 billion by 2025, with a compound annual growth rate (CAGR) of 10.8%.
By 2029, the global cardiac marker market is projected to grow to $20.35 billion, exhibiting a compound annual growth rate (CAGR) of 13.0%.
Download Your Free Sample of the 2025 Cardiac Marker Market Report and Uncover Key Trends Now!The key drivers in the cardiac marker market are:
• Rising burden of lifestyle-related diseases
• Increasing use of remote monitoring and telemedicine
• Growing focus on personalized medicine and precision diagnostics
• Growing adoption of point-•of-care testing (POCT)
The cardiac marker market covered in this report is segmented –
1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions
The key trends in the cardiac marker market are:
• Biomarker discovery and validation is an emerging trend shaping the future of the Cardiac Marker Global Market.
• Personalized medicine approaches are increasingly influencing the market.
• Technological advancements in assay platforms are expected to play a significant role in the future developments of the market.
• The integration of high-sensitivity troponin tests is a rising trend that is expected to impact the market.
The major players in the cardiac marker market are:
• Abbott Laboratories Inc
North America was the largest region in the cardiac marker market in 2024